Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400086779Phase 4Recruiting
Phase 4, randomised trial of oliceridine in traumatic brain injury (TBI) (2 arms), sponsored by Jining First People's Hospital. Primary endpoints: Duration of ventilator use and Inhibition of respiratory function. Started Jul 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400086779.